Multivitamin use prior to diagnosis may reduce effects of CIPN in breast cancer survi

[News]

Researchers at Roswell Park Cancer Institute, in collaboration with investigators from the cooperative group SWOG, have found that use of multivitamins prior to diagnosis may reduce the risk of neuropathy in breast cancer patients treated with the class of drugs known as taxanes. The team will present their findings at the American Association for Cancer Research Annual Meeting 2016, to be held April 16-20 in New Orleans.

More... (http://www.news-medical.net/news/20160421/Multivitamin-use-prior-to-diagnosis-may-reduce-effects-of-CIPN-in-breast-cancer-survivors.aspx)